Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    23916321 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed HIV Risk Reduction in Subutex Injectors in Tbilisi
Condition: HIV
Interventions: Drug: methadone;   Drug: buprenorphine-naloxone (Suboxone) for 12 weeks

Study has passed its completion date and status has not been verified in more than two years.